Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Human obesity relationship with Ad36 adenovirus and insulin resistance

Abstract

Objectives:

Infection with specific pathogens may lead to increased adiposity: a specific adiposity-promoting effect of Ad36 human adenovirus, without the involvement of neurological mechanisms, was reported. The aim of this study is to investigate whether non-diabetic patients with earlier Ad36 infection show greater degrees of overweight obesity, of Insulin Resistance (IR), assessed by homoeostasis-model assessment (HOMA), and/or of other related factors. Moreover, the relationship, if any, among these factors and an earlier Ad36 infection, and the hypothesis of a mechanism involving IR are investigated.

Subjects:

Ad36 seropositivity is assessed in 68 obese and 135 non-obese subjects, along with body composition, HOMA and laboratory investigations.

Results:

Age, body mass index (BMI), waist–hip ratio, blood pressure, insulin, HOMA and triglycerides are significantly greater in the Ad36 seropositive group. Ad36 seropositivity, along with HOMA and total cholesterol, explains BMI variance. No Ad36 seropositivity effect to HOMA could be envisaged by the same statistical model.

Conclusion:

A significant association of Ad36 seropositivity with obesity and with essential hypertension in human beings is suggested by our study; this association is mostly significant in women. Our results do not support that any Ad36 adipogenic adenovirus effect is operating in human obesity through an insulin-resistance-related mechanism. Ad36 seropositive status could also be a hallmark of a clinical-metabolic profile possibly preceding obesity and diabetes in non-obese patients.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Lyons MJ, Faust IM, Hemmes RB, Buskirk DR, Hirsch J, Zabriskie JB . A virally induced obesity syndrome in mice. Science 1982; 216: 82–85.

    Article  CAS  PubMed  Google Scholar 

  2. Atkinson RL . Could viruses contribute to the worldwide epidemic of obesity? Int J Pediatr Obes 2008; 3 (Suppl 1): 37–43.

    Article  PubMed  Google Scholar 

  3. Greenway F . Virus-induced obesity. Am J Physiol Regul Integr Comp Physiol 2006; 290: R188–R189.

    Article  CAS  PubMed  Google Scholar 

  4. Atkinson RL, Dhurandhar NV, Allison DB, Bowen RL, Israel BA, Albu JB et al. Human adenovirus-36 is associated with increased body weight and paradoxical reduction of serum lipids. Int J Obes (Lond) 2005; 29: 281–286.

    Article  CAS  Google Scholar 

  5. Whigham LD, Israel BA, Atkinson RL . Adipogenic potential of multiple human adenoviruses in vivo and in vitro in animals. Am J Physiol Regul Integr Comp Physiol 2006; 290: R190–R194.

    Article  CAS  PubMed  Google Scholar 

  6. So PW, Herlihy AH, Bell JD . Adiposity induced by adenovirus 5 inoculation. Int J Obes (Lond) 2005; 29: 603–606.

    Article  CAS  Google Scholar 

  7. Christakis NA, Fowler JH . The spread of obesity in a large social network over 32 years. N Engl J Med 2007; 357: 370–379.

    Article  CAS  PubMed  Google Scholar 

  8. Cohen-Cole E, Fletcher JM . Is obesity contagious? Social networks vs. environmental factors in the obesity epidemic. J Health Econ 2008; 27: 1382–1387.

    Article  PubMed  Google Scholar 

  9. Skilton MR, Sieveking DP, Harmer JA, Franklin J, Loughnan G, Nakhla S et al. The effects of obesity and non-pharmacological weight loss on vascular and ventricular function and structure. Diabetes Obes Metab 2008; 10: 874–884.

    Article  CAS  PubMed  Google Scholar 

  10. Niswender KD, Beech BM . Obesity: increasing awareness of novel environmental factors. Diabetes 2008; 57: 1786–1787.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Trovato GM, Catalano D, Martines GF, Spadaro D, Di Nuovo S . Psychological stress measure in type 2 diabetes. Eur Rev Med Pharmacol Sci 2006; 10: 69–74.

    CAS  PubMed  Google Scholar 

  12. McLaughlin T, Schweitzer P, Carter S, Yen CG, Lamendola C, Abbasi F et al. Persistence of improvement in insulin sensitivity following a dietary weight loss programme. Diabetes Obes Metab 2008; 10: 1186–1194.

    CAS  PubMed  Google Scholar 

  13. Catalano D, Trovato GM, Martines GF, Randazzo M, Tonzuso A . Bright liver, body composition and insulin resistance changes with nutritional intervention: a follow-up study. Liver Int 2008; 28: 1280–1287.

    Article  CAS  PubMed  Google Scholar 

  14. Pasarica M, Shin AC, Yu M, Ou Yang HM, Rathod M, Jen KL et al. Human adenovirus 36 induces adiposity, increases insulin sensitivity, and alters hypothalamic monoamines in rats. Obesity 2006; 14: 1905–1913.

    Article  CAS  PubMed  Google Scholar 

  15. Rogers PM, Mashtalir N, Rathod MA, Dubuisson O, Wang Z, Dasuri K et al. Metabolically favorable remodeling of human adipose tissue by human adenovirus type 36. Diabetes 2008; 57: 2321–2331.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Hayashi T, Boyko EJ, McNeely MJ, Leonetti DL, Kahn SE, Fujimoto WY . Visceral adiposity, not abdominal subcutaneous fat area, is associated with an increase in future insulin resistance in Japanese Americans. Diabetes 2008; 57: 1269–1275.

    Article  CAS  PubMed  Google Scholar 

  17. Trovato GM, Catalano D, Caruso G, Squatrito R, Venturino M, Degano C et al. Relationship between cardiac function and insulin resistance in obese patients. Diabetes Nutr Metab 2001; 14: 325–328.

    CAS  PubMed  Google Scholar 

  18. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC . Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412–419.

    Article  CAS  PubMed  Google Scholar 

  19. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G et al. 2007 Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2007; 28: 1462–1536.

    PubMed  Google Scholar 

  20. Vague P, Nguyen L . Rationale and methods for the estimation of insulin secretion in a given patient: from research to clinical practice. Diabetes 2002; 51 (Suppl 1): S240–S244.

    Article  CAS  PubMed  Google Scholar 

  21. Rutter MK, Wilson PW, Sullivan LM, Fox CS, D'Agostino Sr RB, Meigs JB . Use of alternative thresholds defining insulin resistance to predict incident type 2 diabetes mellitus and cardiovascular disease. Circulation 2008; 117: 1003–1009.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Allison DB, Downey M, Atkinson RL, Billington CJ, Bray GA, Eckel RH et al. Obesity as a disease: a white paper on evidence and arguments commissioned by the Council of the Obesity Society. Obesity 2008; 16: 1161–1177.

    Article  PubMed  Google Scholar 

  23. Fernández-Real JM, Ferri MJ, Vendrell J, Ricart W . Burden of infection and fat mass in healthy middle-aged men. Obesity 2007; 15: 245–252.

    Article  PubMed  Google Scholar 

  24. Aronne LJ . Cardiovascular risk reduction: focus on managing cardiometabolic risk factors. Obesity 2006; 14: 119S–120S.

    Article  Google Scholar 

  25. Boorsma W, Snijder MB, Nijpels G, Guidone C, Favuzzi AM, Mingrone G et al. Body composition, insulin sensitivity, and cardiovascular disease profile in healthy Europeans. Obesity 2008; 16: 2696–2701.

    Article  CAS  PubMed  Google Scholar 

  26. Alexander CM, Landsman PB, Grundy SM . The influence of age and body mass index on the metabolic syndrome and its components. Diabetes Obes Metab 2008; 10: 246–250.

    Article  CAS  PubMed  Google Scholar 

  27. Vasilakopoulou A, le Roux CW . Could a virus contribute to weight gain? Int J Obes (Lond) 2007; 31: 1350–1356.

    Article  CAS  Google Scholar 

  28. Vangipuram SD, Yu M, Tian J, Stanhope KL, Pasarica M, Havel PJ et al. Adipogenic human adenovirus-36 reduces leptin expression and secretion and increases glucose uptake by fat cells. Int J Obes (Lond) 2007; 31: 87–96.

    Article  CAS  Google Scholar 

  29. Bouwman JJ, Visseren FL, Bouter KP, Diepersloot RJ . Infection-induced inflammatory response of adipocytes in vitro. Int J Obes (Lond) 2008; 32: 892–901.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to G M Trovato.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Trovato, G., Castro, A., Tonzuso, A. et al. Human obesity relationship with Ad36 adenovirus and insulin resistance. Int J Obes 33, 1402–1409 (2009). https://doi.org/10.1038/ijo.2009.196

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ijo.2009.196

Keywords

This article is cited by

Search

Quick links